What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Cancer research, Hepatocellular carcinoma, Carcinoma, Immunology and Internal medicine.
His Cancer research research incorporates themes from Cell, Progenitor cell, Carcinogenesis, microRNA and TLR4.
Hongyang Wang studies Hepatocellular carcinoma, focusing on Liver cancer in particular.
Hongyang Wang has researched Carcinoma in several fields, including Microvesicles and Cell culture.
His work deals with themes such as Liver tumor and Macrophage, which intersect with Immunology.
Hongyang Wang combines subjects such as Gastroenterology, Endocrinology, Surgery and Oncology with his study of Internal medicine.
His most cited work include:
- EpCAM-positive hepatocellular carcinoma cells are tumor initiating cells with stem/progenitor cell features (848 citations)
- The global burden of liver disease: The major impact of China (565 citations)
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA (512 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Hepatocellular carcinoma, Internal medicine, Liver cancer and Cancer.
His research investigates the connection between Cancer research and topics such as Metastasis that intersect with problems in Gene knockdown.
His study in Hepatocellular carcinoma is interdisciplinary in nature, drawing from both Hepatectomy, Carcinoma, Gene and Hepatitis B virus.
His study looks at the relationship between Internal medicine and fields such as Endocrinology, as well as how they intersect with chemical problems.
His Liver cancer research integrates issues from Cancer stem cell, Stem cell, Cell culture and Cell growth.
In his study, Cell biology is inextricably linked to Apoptosis, which falls within the broad field of Cell growth.
He most often published in these fields:
- Cancer research (67.89%)
- Hepatocellular carcinoma (40.69%)
- Internal medicine (29.90%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (67.89%)
- Hepatocellular carcinoma (40.69%)
- Cancer (16.42%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Hepatocellular carcinoma, Cancer, Internal medicine and Liver cancer.
His biological study spans a wide range of topics, including Cancer cell, Apoptosis, Metastasis, Necroptosis and Kinase.
His studies deal with areas such as Immunohistochemistry, Cirrhosis, Mutation and Hepatitis B virus as well as Hepatocellular carcinoma.
His study looks at the relationship between Cancer and topics such as Gene, which overlap with Beta oxidation and Function.
The various areas that he examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology.
His Liver cancer research incorporates elements of Cell culture, Carcinoma and Stem cell.
Between 2017 and 2021, his most popular works were:
- Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing (309 citations)
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. (265 citations)
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. (265 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Hongyang Wang mainly investigates Cancer research, Hepatocellular carcinoma, Cancer, Liver cancer and Internal medicine.
His Cancer research research includes themes of Cell culture, Cancer cell, microRNA, Metastasis and Kinase.
His Hepatocellular carcinoma research is multidisciplinary, incorporating elements of Carcinogenesis, T cell, Methylation and Cyclophosphamide.
Hongyang Wang has included themes like Biomarker, Apoptosis, Programmed cell death and SOX2 in his Cancer study.
Hongyang Wang works mostly in the field of Liver cancer, limiting it down to topics relating to Carcinoma and, in certain cases, Tumor-Derived, Microvesicles, Stroma, Cell signaling and Hepatectomy, as a part of the same area of interest.
His Internal medicine research is multidisciplinary, relying on both Cytotoxic T cell, Endocrinology, Antibody and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
